In the SURMOUNT-1 clinical trial, participants lost approximately 15-20% of their body weight over 72 weeks, with results varying by dose
novel peptides like retatrutide, GLP-3) is under development ( [35] )
Clinical Efficacy Fueling Demand (Weight Loss & Diabetes) At the heart of the GLP-1 phenomenon is their undeniable clinical efficacy
This willingness to observe and adapt, rather than rigidly sticking to one plan, is how treatment accommodates the individual variation that is simply a fact of addiction care
High-protein foods that increase GLP-1 include: eggs fish chicken lean meats Greek yogurt tofu legumes These foods support gut health, which is closely linked to GLP-1 production
Moreover, the risk of heart failure hospitalization was augmented irrespective of age category [84], being highest among patients with elevated levels of natriuretic peptides, previous heart failure, or chronic kidney disease [85]